Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development

by John Porter, Ali Taher, Vip Viprakasit, Antonis Kattamis, Thomas D. Coates, Maciej Garbowski, Franz Dürrenberger, Vania Manolova, Frank Richard, M. Domenica Cappellini
Published 2022